Compare ACIW & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIW | BLLN |
|---|---|---|
| Founded | 1975 | 2016 |
| Country | United States | United States |
| Employees | N/A | 713 |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 3.7B |
| IPO Year | 1996 | N/A |
| Metric | ACIW | BLLN |
|---|---|---|
| Price | $41.87 | $83.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $62.50 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 685.8K | 380.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.09 | N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $1,009,780,000.00 | N/A |
| Revenue This Year | $9.67 | $46.29 |
| Revenue Next Year | $7.41 | $30.14 |
| P/E Ratio | $20.45 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.05 | $61.96 |
| 52 Week High | $55.45 | $138.70 |
| Indicator | ACIW | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 49.96 | 53.21 |
| Support Level | $38.70 | $79.33 |
| Resistance Level | $43.01 | $98.48 |
| Average True Range (ATR) | 1.34 | 6.77 |
| MACD | 0.23 | 0.40 |
| Stochastic Oscillator | 39.16 | 41.88 |
ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm's products are sold and supported directly and through distribution networks covering three geographic regions - the Americas, EMEA, and Asia Pacific. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but the majority of the revenue is generated in the United States and EMEA regions. The company's operating segment includes Payment Software and Biller. The company generates the majority of its revenue from the Payment Software segment.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.